These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18059393)

  • 21. H2AFX polymorphisms are associated with decreased risk of diffuse large B cell lymphoma in Koreans.
    Jin XM; Kim HN; Shin MH; Lee IK; Lee JS; Lee JH; Kim HJ; Choi JS; Juhng SW; Choi C
    DNA Cell Biol; 2011 Dec; 30(12):1039-44. PubMed ID: 21631283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States).
    Ward MH; Zahm SH; Weisenburger DD; Gridley G; Cantor KP; Saal RC; Blair A
    Cancer Causes Control; 1994 Sep; 5(5):422-32. PubMed ID: 7999964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insecticide use and risk of non-Hodgkin lymphoma subtypes: A subset meta-analysis of the North American Pooled Project.
    Kachuri L; Beane Freeman LE; Spinelli JJ; Blair A; Pahwa M; Koutros S; Hoar Zahm S; Cantor KP; Weisenburger DD; Pahwa P; Dosman JA; McLaughlin JR; Demers PA; Harris SA
    Int J Cancer; 2020 Dec; 147(12):3370-3383. PubMed ID: 32574374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
    Chang CM; Wang SS; Dave BJ; Jain S; Vasef MA; Weisenburger DD; Cozen W; Davis S; Severson RK; Lynch CF; Rothman N; Cerhan JR; Hartge P; Morton LM
    Int J Cancer; 2011 Aug; 129(4):938-47. PubMed ID: 20949561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.
    Cerhan JR; Engels EA; Cozen W; Davis S; Severson RK; Morton LM; Gridley G; Hartge P; Linet M
    Int J Cancer; 2008 Aug; 123(4):888-94. PubMed ID: 18506687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M;
    Ann Oncol; 2003 Jun; 14(6):881-93. PubMed ID: 12796026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin's lymphoma: NCI-SEER case-control study, 1998-2000.
    Lim U; Schenk M; Kelemen LE; Davis S; Cozen W; Hartge P; Ward MH; Stolzenberg-Solomon R
    Am J Epidemiol; 2005 Nov; 162(10):953-64. PubMed ID: 16221809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
    Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
    Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
    Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
    Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study.
    Kim JH; Bang YJ; Park BJ; Yoo T; Kim CW; Kim TY; Heo DS; Lee HS; Kim NK
    Jpn J Cancer Res; 2002 May; 93(5):471-7. PubMed ID: 12036441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study.
    Cocco P; t'Mannetje A; Fadda D; Melis M; Becker N; de Sanjosé S; Foretova L; Mareckova J; Staines A; Kleefeld S; Maynadié M; Nieters A; Brennan P; Boffetta P
    Occup Environ Med; 2010 May; 67(5):341-7. PubMed ID: 20447988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.
    Chau I; Harries M; Cunningham D; Hill M; Ross PJ; Archer CD; Norman AR; Wotherspoon A; Koh DM; Gill K; Uzzell M; Prior Y; Catovsky D
    Br J Haematol; 2003 Mar; 120(6):970-7. PubMed ID: 12648066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-Hodgkin's lymphoma in the Netherlands: results from a population-based registry.
    Krol AD; le Cessie S; Snijder S; Kluin-Nelemans JC; Kluin PM; Noordijk EM
    Leuk Lymphoma; 2003 Mar; 44(3):451-8. PubMed ID: 12688314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.
    Baecklund E; Sundström C; Ekbom A; Catrina AI; Biberfeld P; Feltelius N; Klareskog L
    Arthritis Rheum; 2003 Jun; 48(6):1543-50. PubMed ID: 12794821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies.
    Kane EV; Bernstein L; Bracci PM; Cerhan JR; Costas L; Dal Maso L; Holly EA; La Vecchia C; Matsuo K; Sanjose S; Spinelli JJ; Wang SS; Zhang Y; Zheng T; Roman E; Kricker A;
    Ann Oncol; 2013 Feb; 24(2):433-441. PubMed ID: 22967995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
    Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.